Aldo Mele, MSc, is currently a senior scientist 2 in the diagnostics R&D group for Horizon Discovery, a PerkinElmer company. He obtained his MSc in biotechnology from Columbia University, New York. Before joining Horizon Discovery, he worked in the protein production department at Sanofi-Aventis and the molecular neuro oncology laboratory at The Rockefeller University. His present role at Horizon involves the development of diagnostic reference standards for use in the oncology and prenatal clinical settings.
The commutability, flexibility, and genomic complexity of cell line-derived reagents provide gold-standard controls for assay development
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.